Pembrolizumab and low-dose, single-fraction radiotherapy for patients with relapsed or refractory multiple myeloma: a prospective, single-centre, single-group, open-label, phase 2 pilot trial in the USA
| Autor: | Khan, Mohammad K *, Nasti, Tahseen H, Qian, Joshua Y, Kleber, Troy J, Switchenko, Jeffrey M, Kaufman, Jonathan L, Nooka, Ajay J, Dhodapkar, Madhav V, Buchwald, Zachary S, Obiekwe, Daby, Lonial, Sagar, Ahmed, Rafi |
|---|---|
| Zdroj: | In The Lancet Haematology July 2024 11(7):e510-e520 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|